|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
8.280 +0.060 (+0.730%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 14,634 | -3.259% | 15,127 | 15,620 | 16,121 | 16,651 |
| Property, plant, equip. & others | 739,056 | -0.959% | 746,213 | 724,633 | 675,773 | 661,309 |
| Land & other Lease Assets | 124,652 | -3.210% | 128,786 | 133,815 | 123,675 | 126,808 |
| Intangible Assets | 283,140 | -9.222% | 311,904 | 341,664 | 371,423 | 396,071 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 68,432 | 1.113% | 67,679 | 91,177 | 104,564 | 97,599 |
| 1,229,914 | -3.134% | 1,269,709 | 1,306,909 | 1,291,556 | 1,298,438 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 367,087 | 32.964% | 276,080 | 243,035 | 227,374 | 210,684 | |
| Trade Receivables | 255,838 | -1.435% | 259,562 | 351,226 | 448,540 | 763,806 | |
| Cash & Bank Balances | 2,748,262 | 12.166% | 2,450,173 | 2,196,323 | 1,940,273 | 1,383,232 | |
| Other Current Assets | 906,893 | 42.402% | 636,856 | 265,245 | 42,510 | 51,926 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 4,278,080 | 18.092% | 3,622,671 | 3,055,829 | 2,658,697 | 2,409,648 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 83,098 | 38.749% | 59,891 | 66,638 | 50,889 | 55,520 | ||
| S-T Debt & Leases | 507,636 | 11.758% | 454,229 | 602,426 | 549,414 | 553,567 | ||
| Other Current Liabilities | 904,262 | 8.118% | 836,368 | 688,343 | 731,560 | 687,207 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 1,494,996 | 10.700% | 1,350,488 | 1,357,407 | 1,331,863 | 1,296,294 | |||
| Net Current Assets | 2,783,084 | 22.485% | 2,272,183 | 1,698,422 | 1,326,834 | 1,113,354 | ||
| Total Assets Less Current Liabilities | 4,012,998 | 13.301% | 3,541,892 | 3,005,331 | 2,618,390 | 2,411,792 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 3,898 | -34.454% | 5,947 | 8,547 | 0 | 0 | |||
| Other Non-current Liabilities | 90,388 | -6.759% | 96,940 | 86,003 | 101,892 | 105,031 | |||
| 94,286 | -8.360% | 102,887 | 94,550 | 101,892 | 105,031 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 63,812 | 0.571% | 63,450 | 64,800 | 64,424 | 68,033 | ||||
| Reserves | 3,562,691 | 15.608% | 3,081,689 | 2,552,905 | 2,155,943 | 1,926,051 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 3,626,503 | 15.305% | 3,145,139 | 2,617,705 | 2,220,367 | 1,994,084 | ||||
| Non-controlling Interests | 292,209 | -0.564% | 293,866 | 293,076 | 296,131 | 312,677 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 3,918,712 | 13.949% | 3,439,005 | 2,910,781 | 2,516,498 | 2,306,761 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 532,903 | 18.224% | 450,758 | 482,495 | 473,870 | 463,879 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 25/11/2024 09:47 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 399,765 |
| %Change | 14.910% |
| EPS / (LPS) | RMB 0.499 |
| NBV Per Share (¥) | RMB 4.383 |